Naphthalene Sulfonic Acids and Salts (NSAs) Group

Information sheet

Naphthalene Sulfonic Acids and Salts (NSAs) Group

These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 6 of 7 substances referred to collectively as the Naphthalene Sulfonic Acids and Salts (NSAs) Group.

Summary of publications
Timelines
Background

Summary of publications
Substance group	CAS RN	Acronym	DSL name	Draft screening assessment	Proposed conclusion on section 64 criteria	Follow-up activities
NSAs Group	1321-69-3^{Footnote a}	NaNSA	Naphthalenesulfonic acid, sodium salt	HTML	Does not meet	None planned at this time
	25322-17-2^{Footnote a}, ^{Footnote c}	DNNSA	Naphthalenesulfonic acid, dinonyl-
	25619-56-1^{Footnote a}, ^{Footnote c}	BaDNNSA	Naphthalenesulfonic acid, dinonyl-, barium salt
	57855-77-3^{Footnote a}, ^{Footnote b}	CaDNNSA	Naphthalenesulfonic acid, dinonyl-, calcium salt
	60223-95-2^{Footnote a}, ^{Footnote c}	DNNDSA	Naphthalenedisulfonic acid, dinonyl-
	68425-61-6^{Footnote a}	CDINSA	Naphthalenesulfonic acid, bis(1-methylethyl)-, compd. with cyclohexanamine (1:1)
Footnote a Substance is a UVCB (unknown or variable composition, complex reaction products, or biological materials). Return to footnote a referrer Footnote b This substance was not identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999 but was included in this assessment as it was considered a priority on the basis of other human health concerns. Return to footnote b referrer Footnote c This substance was determined to be a priority as a result of the approach described for the Identification of Risk Assessment Priorities. Return to footnote c referrer

Timelines
Date	Activity
July 2021	Anticipated publication of the final screening assessment.
July 4, 2020	Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 27.

Background

One other substance was identified as being a part of the NSAs Group at the outset of the third phase of the CMP. This substance was subsequently determined to be of low concern to both human health and the environment, through other approaches. Conclusions for the substance with CAS RN 25638-17-9 are provided in the Final Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure.

Language selection

Search

Naphthalene Sulfonic Acids and Salts (NSAs) Group

Information sheet

Background

Thank you for your help!